A new study shows that memory pathology in older mice with Alzheimer’s disease can be reversed with treatment. The study by researchers from the Montreal Neurological Institute and Hospital - The Neuro, at McGill University and at Université de Montréal found that blocking the activity of a specific receptor in the brain of mice with advanced Alzheimer’s disease (AD) recovers memory and cerebrovascular function. The results, published in the Journal of Neuroinflammation in May, also suggest an underlying mechanism of AD as a potential target for new therapies.
What is ALS?
Amyotrophic Lateral Sclerosis (ALS) also known as Lou Gehrig’s disease, is a neurodegenerative disease in which progressive muscle weakness leads to paralysis. ALS is a result of the death of motor neurons (nerve cells) in the brain and spinal cord that control voluntary muscle movement. Most people survive less than five years following diagnosis, but a small percentage of patients live for ten years or even longer. So far, there is no cure. About 3,000 Canadian adults have ALS and less than 1 in 10 patients have a family history of the disease.
Dr. Frederick Andermann, neurologist and researcher at the Montreal Neurological Institute and Hospital – The Neuro, McGill University has been named an Officer of the Order of Quebec. Dr. Andermann is among 33 distinguished recipients who will be decorated by Premier of Quebec Pauline Marois at a ceremony on June 6, 2013 at the salle du Conseil législatif de l’hôtel du Parlement.
Study compares data from hundreds of people in childhood and old age
A new study shows compelling evidence that associations between cognitive ability and cortical grey matter in old age can largely be accounted for by cognitive ability in childhood. The joint study by the Montreal Neurological Institute and Hospital, The Neuro, McGill University and the University of Edinburgh, UK was published today, June 4 in Molecular Psychiatry.
Local students compete and put their science skills and knowledge to the test at Let’s Talk Science’s All Science Challenge
MONTREAL, QC – Approximately 110 Grade 6, 7 and 8 students from 14 local schools are getting ready to compete in Let’s Talk Science’s All Science Challenge on May 31st at the Montreal Neurological Institute and Hospital – The Neuro, McGill University. This event is one of 23 All Science Challenge competitions happening at Let’s Talk Science Outreach locations across the country in April and May.
Dr. Robert J.
Research opens door to new drug therapies for Parkinson’s disease
Live 3D images of brain’s vasculature will improve patient diagnosis and treatment
The diagnosis and treatment of potentially life-threatening neurological conditions such as aneurysms and strokes will be significantly improved as a result of cutting-edge technology at the Montreal Neurological Institute and Hospital - The Neuro, at McGill University and the MUHC. The new angiosuite, inaugurated today, offers significant advantages to patients and physicians including most importantly, improved safety and outcomes.
New study shows what happens in the brain to make music rewarding
A new study reveals what happens in our brain when we decide to purchase a piece of music when we hear it for the first time. The study, conducted at the Montreal Neurological Institute and Hospital – The Neuro, McGill University and published in the journal Science on April 12, pinpoints the specific brain activity that makes new music rewarding and predicts the decision to purchase music.
What is Parkinson’s Disease?
Powerful treatment improves patients’ lives and provides new insight into mechanisms of the disease
A team of basic and clinical scientists led by the University of Montreal Hospital* Research Centre’s (CRCHUM) Dr. Nathalie Arbour has opened the door to significantly improved treatments for the symptoms of Multiple Sclerosis (MS). In a study selected as among the top 10% most interesting articles published in the Journal of Immunology, the team identifies the elevated presence in MS patients of a type of white blood cell (CD4 T cell) that expresses NKG2C, a highly-toxic molecule harmful to brain tissues.
March - National Epilepsy Awareness Month
The Neuro has been at the forefront of epilepsy treatment and research for over half a century. The development of “The Montreal Procedure” by Dr. Wilder Penfield and his colleagues revolutionized the surgical treatment for epilepsy allowing thousands of patients to start new lives – free of seizures.
Thirty-two students from six Montreal area high schools will assemble at the Montreal Neurological Institute and Hospital – The Neuro at McGill University on February 21st to be quizzed about synapses, axons and other cerebral facts in the international contest known as the Brain Bee. The winner will go on to the Canadian National Brain Bee at McMaster University in Hamilton, ON. The national winner travels to Vienna or Hawaii for the International Brain Bee.
Montreal researchers find that music lessons before age seven create stronger connections in the brain
If you started piano lessons in grade one, or played the recorder in kindergarten, thank your parents and teachers. Those lessons you dreaded – or loved – helped develop your brain. The younger you started music lessons, the stronger the connections in your brain.